Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Change in Accured Expenses (2020 - 2025)

Bolt Biotherapeutics (BOLT) has disclosed Change in Accured Expenses for 6 consecutive years, with -$197000.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 92.7% to -$197000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.4 million through Dec 2025, down 11.2% year-over-year, with the annual reading at -$5.4 million for FY2025, 11.2% down from the prior year.
  • Change in Accured Expenses hit -$197000.0 in Q4 2025 for Bolt Biotherapeutics, up from -$1.9 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $5.6 million in Q3 2022 to a low of -$6.6 million in Q1 2023.
  • Historically, Change in Accured Expenses has averaged -$214100.0 across 5 years, with a median of -$142500.0 in 2021.
  • Biggest five-year swings in Change in Accured Expenses: skyrocketed 4015.69% in 2021 and later plummeted 2618.18% in 2022.
  • Year by year, Change in Accured Expenses stood at -$549000.0 in 2021, then surged by 152.28% to $287000.0 in 2022, then soared by 313.94% to $1.2 million in 2023, then tumbled by 327.1% to -$2.7 million in 2024, then skyrocketed by 92.7% to -$197000.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for BOLT at -$197000.0 in Q4 2025, -$1.9 million in Q3 2025, and -$840000.0 in Q2 2025.